Resources Contact Us Home
Browse by Category: Main > Health & Medicine
Class Information
Number: 514/103
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Phosphorus containing other than solely as part of an inorganic ion in an addition salt doai > Two or more phosphorus atoms directly or indirectly bonded together by only covalent bonds > Phosphorus acid ester of polyhydric alcohol or thioalcohol (e.g., p-x-r-x-p group, etc., wherein x is chalcogen and r is the residue of the polyhydric alcohol or thioalcohol)
Description: Subject matter in which the organo-phosphorus compound is a phosphorus acid ester of a polyhydric alcohol or thioalcohol, e.g., P-X-(R) XP group, etc., wherein X is chalcogen and R is the residue of a polyhydric alcohol.

Sub-classes under this class:

Class Number Class Name Patents
514/104 Benzene ring in the alcohol moiety 32

Patents under this class:
1 2

Patent Number Title Of Patent Date Issued
8569269 Chirally correct retinal cyclodextrin hemiacetals for treating skin disorder Oct. 29, 2013
8236784 Composition comprising threitol phosphate and salts thereof Aug. 7, 2012
8236755 Opioid depot formulations Aug. 7, 2012
8236292 Liquid depot formulations Aug. 7, 2012
8178514 Inositol pyrophosphates, and methods of use thereof May. 15, 2012
7915238 Immunomodulatory compounds and methods of use thereof Mar. 29, 2011
7833993 Immunomodulatory compounds and methods of use thereof Nov. 16, 2010
7833992 Conjugates and compositions for cellular delivery Nov. 16, 2010
7517858 Prodrugs of pharmaceuticals with improved bioavailability Apr. 14, 2009
7511095 Thioester-terminated water soluble polymers and method of modifying the N-terminus of a polypeptide therewith Mar. 31, 2009
7109181 Joint lubrication with P2Y purinergic receptor agonists Sep. 19, 2006
7084126 Methods and compositions for enhancing cellular function through protection of tissue components Aug. 1, 2006
7053150 Segmented polymers and their conjugates May. 30, 2006
6774180 Synthesis of high molecular weight non-peptidic polymer derivatives Aug. 10, 2004
6680307 Use of ibandronate for promoting osseointegration of endoprostheses Jan. 20, 2004
6677320 Parenteral bisphosphonate composition with improved local tolerance Jan. 13, 2004
6627660 Stabilized thyroxine compounds Sep. 30, 2003
6605603 Uses of 1-amino-3-(N,N-dimethylamino)-propylidene-1,1-bisphosphonic acid Aug. 12, 2003
6436913 Use of estramustine phosphate in the treatment of bone metastasis Aug. 20, 2002
6337078 Controlled delivery compositions and processes for treating organisms in a column of water or land Jan. 8, 2002
6326363 Methylenebisphosphonic acid derivatives Dec. 4, 2001
6316430 Insecticidal and miticidal compositions Nov. 13, 2001
6303588 Therapeutic methods utilizing naturally derived bio-active complexes and delivery systems therefor Oct. 16, 2001
6221856 Inositol derivatives for inhibiting superoxide anion production Apr. 24, 2001
6200961 Concentrates of organophosphorous insecticides Mar. 13, 2001
6114316 Combination of bisphosphonate and tetracycline Sep. 5, 2000
5998485 Method for modulating immune response with inositol Dec. 7, 1999
5955453 Membrane-permeant phosphoinositides Sep. 21, 1999
5885974 Therapeutic methods utilizing naturally derived bio-active complexes and delivery systems therefor Mar. 23, 1999
5846957 Use of an ester of inositoltrisphosphate for the preparing of medicaments Dec. 8, 1998
5827838 Method for the treatment of diseases related with protein isoprenylation Oct. 27, 1998
5827837 Polyanion anti-inflammatory agents Oct. 27, 1998
5760022 Pharmaceutical composition with improved bioavailability of inositol phosphate Jun. 2, 1998
5726164 Nanosuspensions for intravenous administration Mar. 10, 1998
5726163 Dermatologic composition Mar. 10, 1998
5668120 Iontophoretic delivery of bisphosphonates to the alveolar bone Sep. 16, 1997
5663179 Certain isoquinoline derivatives having anti-tumor properties Sep. 2, 1997
5628986 Oral compositions May. 13, 1997
5618804 Methanediphosphonic acid derivative, process for production thereof and use for pharmaceuticals Apr. 8, 1997
5616571 Bisphosphonates prevent bone loss associated with immunosuppressive therapy Apr. 1, 1997
5614511 Cosmetic compositions for treating itchy skin Mar. 25, 1997
5614510 Pharmaceutical composition with improved bioavailability of inositol phosphate Mar. 25, 1997
5545632 Method of treating retroviral disease Aug. 13, 1996
5512552 Bisphosphonic acid derivatives, and pharmaceutical use Apr. 30, 1996
5464754 Assay and substrate for arachidonoyl-specific phospholipase A2 Nov. 7, 1995
5415855 Cosmetic composition May. 16, 1995
5407923 Substituted derivatives of deoxymyoinositol, process for their preparation and their use in medicaments Apr. 18, 1995
5407924 Method of treating pain using inositol triphosphate Apr. 18, 1995
5360797 Bisphosphonic acid derivatives useful as anti-arthritic agents Nov. 1, 1994
5344825 Methanediphosphonic acid formulations with ion exchangers Sep. 6, 1994

1 2

  Recently Added Patents
Monitoring and correcting upstream packet loss
Reaction medium for detecting and/or identifying bacteria of the Legionella genus
Apparatus for performing timer management regarding a system timer scheduler service, and associated method
Integrated disk driving module including a stepping motor integrally formed with a base unit
Multi charged particle beam writing apparatus and multi charged particle beam writing method
Memory device and method for repairing a semiconductor memory
Direct converting apparatus, method for controlling the same, and control signal generation device
  Randomly Featured Patents
High purity nanoscale metal oxide powders and methods to produce such powders
Bottle with cap
LED surface light source and projection system using the same
Surgical device
Process for heat transfer with dilute phase fluidized bed
Leakage current monitor
Method for a multi-dimensional measurement of magnetic resonance in defined small volume regions of a solid-state sample
Computer display optimizer
Urea concentration identification device for urea solution
Deriving central aortic systolic pressure and analyzing arterial waveform data to derive central aortic systolic pressure values